Helminth Infections and Allergic Diseases: from the Th2 Paradigm to Regulatory Networks

Overview

Journal Clin Rev Allergy Immunol

Specialty Allergy & Immunology

Date 2004 Feb 3

PMID 14755073

Citations 12

Authors

Andre Capron

David Dombrowicz

Monique Capron

Affiliations

Soon will be listed here.

Abstract

Both helminth infections and allergic diseases are characterized by a Th2 response. The former mostly affects developing countries while the later is steadily increasing in westernized countries, since most parasitic diseases have been eradicated. However, besides the cytokine pattern, both pathologies display striking similarities regarding the cell types involved in the process, the mucosal component of the inflammatory reaction and the immunoglobulin isotypes produced, IgE and IgA. Recent advances also suggest that allergic pathologies and some other inflammatory diseases arise from a similar dysfunction of the regulatory mechanisms, existing within the immune system. Such a dysregulation leads to a rupture of tolerance towards allergen. Chronic and moderate helminth infections might be beneficial to the induction of various regulatory mechanisms, involving specific regulatory cell populations (dendritic cells and lymphocytes), inhibitory receptors, blocking antibodies and two prominent cytokines: IL-10 and TGF-b, which would decrease the incidence of allergic diseases. This mechanism could provide a new vision of the so-called "hygiene hypothesis".

Citing Articles

Prior infection protects against induced hepatic fibrosis.

El-Kady A, Altwaim S, Wakid M, Banjar A, Mohammed K, Alfaifi M Front Vet Sci. 2024; 11:1443267.

PMID: 39439825 PMC: 11494294. DOI: 10.3389/fvets.2024.1443267.

Severely Asthmatic Horses Residing in a Mediterranean Climate Shed a Significantly Lower Number of Parasite Eggs Compared to Healthy Farm Mates.

Simoes J, Sales Luis J, de Carvalho L, Tilley P Animals (Basel). 2023; 13(18).

PMID: 37760328 PMC: 10525552. DOI: 10.3390/ani13182928.

-based helminth therapy in C3(1)-TAg mice does not alter breast tumor onset or progression.

Sauer S, Beinart D, Finn S, Kumar S, Cheng Q, Hwang S Evol Med Public Health. 2021; 9(1):131-138.

PMID: 33738103 PMC: 7953836. DOI: 10.1093/emph/eoab007.

Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis.

Yang J, Zhou Y, Singh R J Immunol Res. 2016; 2016:2395645.

PMID: 27563682 PMC: 4987483. DOI: 10.1155/2016/2395645.

Alteration of the rat cecal microbiome during colonization with the helminth Hymenolepis diminuta.

McKenney E, Williamson L, Yoder A, Rawls J, Bilbo S, Parker W Gut Microbes. 2015; 6(3):182-93.

PMID: 25942385 PMC: 4615828. DOI: 10.1080/19490976.2015.1047128.

References

Khalife J, Capron M, Capron A, Grzych J, Butterworth A, Dunne D . Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies. J Exp Med. 1986; 164(5):1626-40. PMC: 2188460. DOI: 10.1084/jem.164.5.1626. View

Bottcher M, Haggstrom P, Bjorksten B, Jenmalm M . Total and allergen-specific immunoglobulin A levels in saliva in relation to the development of allergy in infants up to 2 years of age. Clin Exp Allergy. 2002; 32(9):1293-8. DOI: 10.1046/j.1365-2222.2002.01470.x. View

Crompton D . The prevalence of Ascariasis. Parasitol Today. 1988; 4(6):162-9. DOI: 10.1016/0169-4758(88)90152-4. View

Demeure C, Rihet P, Abel L, Ouattara M, Bourgois A, Dessein A . Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis. 1993; 168(4):1000-8. DOI: 10.1093/infdis/168.4.1000. View

Remoue F, Rogerie F, Gallissot M, Guyatt H, Neyrinck J, Diakkhate M . Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations. J Infect Dis. 2000; 181(5):1855-9. DOI: 10.1086/315454. View

Wills-Karp M, Santeliz J, Karp C . The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol. 2002; 1(1):69-75. DOI: 10.1038/35095579. View

Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J . Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med. 1992; 175(3):671-82. PMC: 2119142. DOI: 10.1084/jem.175.3.671. View

Ravetch J, Bolland S . IgG Fc receptors. Annu Rev Immunol. 2001; 19:275-90. DOI: 10.1146/annurev.immunol.19.1.275. View

Gascan H, Gauchat J, Aversa G, Van Vlasselaer P, De Vries J . Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J Immunol. 1991; 147(1):8-13. View

10.

Lynch N, Hagel I, Perez M, Di Prisco M, Lopez R, Alvarez N . Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol. 1993; 92(3):404-11. DOI: 10.1016/0091-6749(93)90119-z. View

11.

Ogilvie B, Smithers S, Terry R . Reagin-like antibodies in experimental infections of Schistosoma mansoni and the passive transfer of resistance. Nature. 1966; 209(5029):1221-3. DOI: 10.1038/2091221a0. View

12.

Grzych J, Grezel D, Xu C, Neyrinck J, Capron M, Ouma J . IgA antibodies to a protective antigen in human Schistosomiasis mansoni. J Immunol. 1993; 150(2):527-35. View

13.

Woerly G, Roger N, Loiseau S, Dombrowicz D, Capron A, Capron M . Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes. J Exp Med. 1999; 190(4):487-95. PMC: 2195599. DOI: 10.1084/jem.190.4.487. View

14.

Akdis C, Blesken T, Akdis M, Wuthrich B, Blaser K . Role of interleukin 10 in specific immunotherapy. J Clin Invest. 1998; 102(1):98-106. PMC: 509070. DOI: 10.1172/JCI2250. View

15.

Capron A, Dessaint J, Capron M, Bazin H . Specific IgE antibodies in immune adherence of normal macrophages to Schistosoma mansoni schistosomules. Nature. 1975; 253(5491):474-5. DOI: 10.1038/253474a0. View

16.

Strachan D . Hay fever, hygiene, and household size. BMJ. 1989; 299(6710):1259-60. PMC: 1838109. DOI: 10.1136/bmj.299.6710.1259. View

17.

Maizels R, Holland M, Falcone F, Zang X, Yazdanbakhsh M . Vaccination against helminth parasites--the ultimate challenge for vaccinologists?. Immunol Rev. 1999; 171:125-47. DOI: 10.1111/j.1600-065x.1999.tb01345.x. View

18.

Capron A, Dombrowicz D, Capron M . Regulation of the immune response in experimental and human schistosomiasis: the limits of an attractive paradigm. Microbes Infect. 1999; 1(7):485-90. DOI: 10.1016/s1286-4579(99)80086-0. View

19.

Schwarze J, Cieslewicz G, Joetham A, Sun L, Sun W, Chang T . Antigen-specific immunoglobulin-A prevents increased airway responsiveness and lung eosinophilia after airway challenge in sensitized mice. Am J Respir Crit Care Med. 1998; 158(2):519-25. DOI: 10.1164/ajrccm.158.2.9801014. View

20.

Capron M, Capron A . Immunoglobulin E and effector cells in schistosomiasis. Science. 1994; 264(5167):1876-7. DOI: 10.1126/science.8009216. View